|
|
Previous Article | Table of Contents | Next Article 
Proteoglycan metabolism in normal and inflammatory human macrophages
L Uhlin-Hansen, T Wik, L Kjellen, E Berg, F Forsdahl and SO Kolset
Department of Biochemistry, University of Tromso, Norway.
To study proteoglycan metabolism in inflammatory macrophages, primary
cultures of human macrophages were cultured in the absence and presence of
bacterial lipopolysaccharide (LPS). When exposed to [35S]sulfate, the cells
incorporated the label almost exclusively into chondroitin sulfate
proteoglycan (CSPG), which was recovered from the culture medium and the
cell layer. Cells stimulated with LPS secreted approximately three times
more [35]CSPG into the culture medium than control cells. Furthermore, cell
adhesion was also found to promote proteoglycan secretion; when nonadherent
monocytic cells were induced to adhere, the release of proteoglycan
increased two times. The increased secretion seen in LPS-stimulated
macrophages was partly due to increased biosynthesis, but was mostly due to
increased sorting of CSPG to the secretory pathway. Only about 20% of the
CSPG synthesized in unstimulated cells was secreted, whereas the
corresponding figure in LPS-treated cells was 35%. In both cell types, the
remaining [35S]CSPG was degraded, probably in the lysosomes. The
degradation was a two-step process. First, the [35S]CSPG was rapidly
cleaved to yield free glycosaminoglycan (GAG) chains (t1/2 = 15 to 30
minutes). Secondly, the GAG chains were completely depolymerized (t1/2 = 2
to 3 hours). Neither resting nor LPS-stimulated cells sorted CSPG to
intracellular storage, as is evident in many hematopoietic cells. The
LPS-treated cells synthesized [35S]CSPG of smaller molecular size than did
control cells, with GAG chains of approximate molecular mass of 12 kD
versus 16 kD in control cells. No difference was seen in the disaccharide
composition of the GAG chains; both LPS-stimulated and unstimulated cells
expressed a mixture of 80% to 90% chondroitin 4-sulfate and 10% to 20%
chondroitin 4,6-disulfate. N-terminal sequence and Northern blot analysis
indicate that the core protein of the CSPG secreted by human macrophages is
serglycin.
Volume 82,
Issue 9,
pp. 2880-2889,
11/01/1993
Copyright © 1993 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Malla, E. Berg, L. Uhlin-Hansen, and J.-O. Winberg
Interaction of Pro-matrix Metalloproteinase-9/Proteoglycan Heteromer with Gelatin and Collagen
J. Biol. Chem.,
May 16, 2008;
283(20):
13652 - 13665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Piccard, P. E. Van den Steen, and G. Opdenakker
Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins
J. Leukoc. Biol.,
April 1, 2007;
81(4):
870 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zernichow, M. Abrink, J. Hallgren, M. Grujic, G. Pejler, and S. O. Kolset
Serglycin Is the Major Secreted Proteoglycan in Macrophages and Has a Role in the Regulation of Macrophage Tumor Necrosis Factor-{alpha} Secretion in Response to Lipopolysaccharide
J. Biol. Chem.,
September 15, 2006;
281(37):
26792 - 26801.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Comalada, M. Cardo, J. Xaus, A. F. Valledor, J. Lloberas, F. Ventura, and A. Celada
Decorin Reverses the Repressive Effect of Autocrine-Produced TGF-{beta} on Mouse Macrophage Activation
J. Immunol.,
May 1, 2003;
170(9):
4450 - 4456.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Xaus, M. Comalada, M. Cardo, A. F. Valledor, and A. Celada
Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27Kip1 and p21Waf1
Blood,
October 1, 2001;
98(7):
2124 - 2133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Lemansky and A Hasilik
Chondroitin sulfate is involved in lysosomal transport of lysozyme in U937 cells
J. Cell Sci.,
January 1, 2001;
114(2):
345 - 352.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Mbemba, J. C. Gluckman, and L. Gattegno
Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1{alpha}
Glycobiology,
January 1, 2000;
10(1):
21 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rachmilewitz and M. L. Tykocinski
Differential Effects of Chondroitin Sulfates A and B on Monocyte and B-Cell Activation: Evidence for B-Cell Activation Via a CD44-Dependent Pathway
Blood,
July 1, 1998;
92(1):
223 - 229.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Y. Chang, K. L. Olin, C. Tsoi, T. N. Wight, and A. Chait
Human Monocyte-derived Macrophages Secrete Two Forms of Proteoglycan-Macrophage Colony-stimulating Factor That Differ in Their Ability to Bind Low Density Lipoproteins
J. Biol. Chem.,
June 26, 1998;
273(26):
15985 - 15992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. McGee, H. Teuschler, N. Parthasarathy, and W. D. Wagner
Specific Regulation of Procoagulant Activity on Monocytes
J. Biol. Chem.,
November 3, 1995;
270(44):
26109 - 26115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. J. Edwards, H. Xu, J. C. Obunike, I. J. Goldberg, and W. D. Wagner
Differentiated Macrophages Synthesize a Heparan Sulfate Proteoglycan and an Oversulfated Chondroitin Sulfate Proteoglycan That Bind Lipoprotein Lipase
Arterioscler Thromb Vasc Biol,
March 1, 1995;
15(3):
400 - 409.
[Abstract]
[Full Text]
|
 |
|
|
|